Product
Stelara®
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
An Randomized Comparative Parallel-group Trial of the Safety, Pharmacokinetics, and Immunogenicity of the Drug GNR-068 and the Drug Stelara® After Their Single Subcutaneous Administration to Healthy Volunteers at a Dose of 45 mgStatus: Completed, Estimated PCD: 2022-09-04